Page last updated: 2024-10-26

dilazep and Disease Exacerbation

dilazep has been researched along with Disease Exacerbation in 1 studies

Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guitart, X1
Chern, Y1
Ferré, S1

Other Studies

1 other study available for dilazep and Disease Exacerbation

ArticleYear
Targeting the equilibrative nucleoside transporter ENT1 in Huntington disease.
    Oncotarget, 2017, Feb-21, Volume: 8, Issue:8

    Topics: Age of Onset; Animals; Animals, Genetically Modified; Biomarkers; Brain; Carrier Proteins; Corpus St

2017